Titan Biotech Quarterly Results for Trading Insights
In Sept 2025, Titan Biotech (TITANBIO) reported revenue ₹56 Cr and net profit ₹8 Cr — revenue +40.0% YoY. For annual financials, live price and key ratios, visit Titan Biotech share price chart.
TITANBIO Quarterly Results — Revenue, Profit & EPS Highlights
Titan Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with TITANBIO stock valuation models to assess whether the stock is under or overvalued.
- Revenue of ₹56 Cr in Sept 2025 (+51.4% vs Mar 2025, +40.0% vs Sept 2024)
- Net Profit of ₹8 Cr in Sept 2025 (+100.0% vs Mar 2025, +14.3% vs Sept 2024)
- EBITDA of ₹11 Cr in Sept 2025 (+83.3% vs Mar 2025)
- Operating Margin of 17.0% in Sept 2025 (+4.0pp vs Mar 2025)
- Earnings Per Share of ₹9.40 in Sept 2025 (+91.8% vs Mar 2025)
Titan Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
TITANBIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 56 | 37 | 47 | 40 | 40 | 51.4% | 40.0% |
| Net Profit (₹ Cr) | 8 | 4 | 7 | 7 | 5 | - | - |
| EBITDA (₹ Cr) | 11 | 6 | 10 | 8 | 8 | - | - |
| EPS (₹) | 9.40 | 4.90 | 8.30 | 8.10 | 6.05 | - | - |
| Operating Margin (%) | 17.0% | 13.0% | 19.0% | 19.0% | 18.0% | - | - |
TITANBIO Share Price Trend — 1-Year Movement Across Quarterly Results
Titan Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse TITANBIO FII DII holdings to track promoter, FII and institutional holdings.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
TITANBIO vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap
Titan Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Pidilite Industries
Sept 2025 |
₹138,121.06 Cr | 1326.5 | 3,605 | 585 | +11.9% | - | 16.2% | 233.1 |
|
SRF
Sept 2025 |
₹73,317.72 Cr | 2443.2 | 3,560 | 388 | -16.2% | - | 10.9% | 186.5 |
|
Coromandel Internat…
Sept 2025 |
₹61,764.26 Cr | 2093.6 | 9,771 | 793 | +78.9% | - | 8.1% | 76.6 |
|
Linde
Sept 2025 |
₹61,319.36 Cr | 7240.0 | 650 | 171 | +7.4% | - | 26.3% | 361.1 |
|
Fertilisers & Chemi…
Sept 2025 |
₹55,492.89 Cr | 852.4 | 1,681 | 21 | +48.8% | - | 1.2% | 2663.6 |
All amounts in ₹ Crores